|
|
Volumn 56, Issue 3, 2010, Pages 345-351
|
|
Prostate cancer screening with prostate-specific antigen testing: More answers or more confusion?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DOCETAXEL;
PROSTATE SPECIFIC ANTIGEN;
ZOLEDRONIC ACID;
CANCER DIAGNOSIS;
CANCER MORTALITY;
CANCER RADIOTHERAPY;
CANCER RISK;
CANCER SCREENING;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL TRIAL;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC IMAGING;
DIGITAL RECTAL EXAMINATION;
HORMONAL THERAPY;
HUMAN;
LIFE EXPECTANCY;
MEDICAL SOCIETY;
METASTASIS;
MULTIMODALITY CANCER THERAPY;
NOTE;
OUTCOME ASSESSMENT;
PROSTATE CANCER;
EARLY DETECTION OF CANCER;
HISTORY, 20TH CENTURY;
HISTORY, 21ST CENTURY;
HUMANS;
MALE;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
|
|
EID: 77649194264
PISSN: 00099147
EISSN: 15308561
Source Type: Journal
DOI: 10.1373/clinchem.2009.140046 Document Type: Note |
|
Times cited : (21)
|
|
References (0)
|
